Related Experiment Video
Updated: Jun 27, 2026
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
[Hospital-acquired clostridium difficile-associated diarrhea]
1Clinic Microbiology Laboratory, Beijing Hospital, Ministry of Health, Beijing 100730, China. huyunjian@sina.com
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae
|November 26, 2008
Summary
Clostridium difficile-associated diarrhea (CDAD) is a growing concern in hospitals. Preventing its spread involves proper antimicrobial use, hand hygiene, environmental disinfection, and patient isolation.
Area of Science:
- Infectious Diseases
- Hospital Epidemiology
- Microbiology
Background:
- Clostridium difficile-associated diarrhea (CDAD) is a significant cause of hospital-acquired bacterial diarrhea.
- Mortality and morbidity associated with CDAD are increasing.
- Improper antimicrobial drug use is a primary contributing factor.
Purpose of the Study:
- To highlight the increasing trend of CDAD.
- To identify key factors contributing to CDAD outbreaks.
- To emphasize effective prevention strategies for hospital-acquired CDAD.
Main Methods:
- Review of epidemiological data on hospital-acquired infections.
- Analysis of factors contributing to Clostridium difficile transmission.
- Evaluation of current infection control practices.
Main Results:
- CDAD incidence and severity are on the rise.
- Inappropriate antimicrobial use significantly elevates CDAD risk.
- Effective interventions are available for CDAD prevention.
Conclusions:
- Controlling antimicrobial stewardship is crucial for reducing CDAD.
- Strict adherence to hand hygiene protocols by healthcare workers is essential.
- Thorough environmental disinfection and appropriate patient isolation are vital for preventing CDAD outbreaks.
Related Concept Videos
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...